Pre-exposure Prophylaxis With Various Doses of Hydroxychloroquine Among Healthcare Personnel With High-Risk Exposure to COVID-19: A Randomized Controlled Trial

DOI record: { "DOI": "10.7759/cureus.20572", "ISSN": [ "2168-8184" ], "URL": "http://dx.doi.org/10.7759/cureus.20572", "author": [ { "affiliation": [], "family": "Syed", "given": "Fibhaa", "sequence": "first" }, { "affiliation": [], "family": "Hassan", "given": "Muhammad", "sequence": "additional" }, { "affiliation": [], "family": "Arif", "given": "Mohammad Ali", "sequence": "additional" }, { "affiliation": [], "family": "Batool", "given": "Sadia", "sequence": "additional" }, { "affiliation": [], "family": "Niazi", "given": "Rauf", "sequence": "additional" }, { "affiliation": [], "family": "Laila", "given": "Ume e", "sequence": "additional" }, { "affiliation": [], "family": "Ashraf", "given": "Sadia", "sequence": "additional" }, { "affiliation": [], "family": "Arshad", "given": "Junaid", "sequence": "additional" } ], "container-title": [ "Cureus" ], "content-domain": { "crossmark-restriction": false, "domain": [] }, "created": { "date-parts": [ [ 2021, 12, 21 ] ], "date-time": "2021-12-21T17:19:24Z", "timestamp": 1640107164000 }, "deposited": { "date-parts": [ [ 2021, 12, 21 ] ], "date-time": "2021-12-21T17:19:29Z", "timestamp": 1640107169000 }, "indexed": { "date-parts": [ [ 2021, 12, 22 ] ], "date-time": "2021-12-22T06:42:33Z", "timestamp": 1640155353761 }, "is-referenced-by-count": 0, "issn-type": [ { "type": "print", "value": "2168-8184" } ], "issued": { "date-parts": [ [ 2021, 12, 21 ] ] }, "language": "en", "link": [ { "URL": "https://www.cureus.com/articles/77806-pre-exposure-prophylaxis-with-various-doses-of-hydroxychloroquine-among-healthcare-personnel-with-high-risk-exposure-to-covid-19-a-randomized-controlled-trial", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking" } ], "member": "4492", "original-title": [], "prefix": "10.7759", "published": { "date-parts": [ [ 2021, 12, 21 ] ] }, "published-print": { "date-parts": [ [ 2021, 12, 21 ] ] }, "publisher": "Cureus, Inc.", "reference": [ { "key": "ref1", "unstructured": "WHO Coronavirus (COVID-19) Dashboard. (2021). Accessed. September 7, 2021: https://covid19.who.int/." }, { "DOI": "10.1136/bmj.m3944", "article-title": "Covid-19: risks to healthcare workers and their families", "author": "Karlsson U", "doi-asserted-by": "publisher", "journal-title": "BMJ", "key": "ref2", "unstructured": "Karlsson U, Fraenkel CJ. Covid-19: risks to healthcare workers and their families. BMJ. 2020, 371:m3944. 10.1136/bmj.m3944", "volume": "371", "year": "2020" }, { "DOI": "10.29052/2412-3188.v7.i1.2020.6-8", "article-title": "The chaos of healing: risking mental health amid COVID19 in Pakistan [Short Communication]", "author": "Ahmed S", "doi-asserted-by": "publisher", "journal-title": "Ann psychophysiol", "key": "ref3", "unstructured": "Ahmed S. The chaos of healing: risking mental health amid COVID19 in Pakistan [Short Communication]. Ann psychophysiol. 2020, 7:6-8. 10.29052/2412-3188.v7.i1.2020.6-8", "volume": "7", "year": "2020" }, { "DOI": "10.29052/IJEHSR.v8.i3.2020.109-111", "article-title": "Are countries preparing for a responsible lockdown exit strategy?", "author": "Jane T", "doi-asserted-by": "publisher", "journal-title": "IJEHSR", "key": "ref4", "unstructured": "Jane T, Aziz SA. Are countries preparing for a responsible lockdown exit strategy?. IJEHSR. 2020, 8:109-11. 10.29052/IJEHSR.v8.i3.2020.109-111", "volume": "8", "year": "2020" }, { "DOI": "10.29052/2412-3188.v7.i1.2020.9-18", "article-title": "Psychological response & perceived risk associated with coronavirus disease", "author": "Khan S", "doi-asserted-by": "publisher", "journal-title": "Ann psychophysiol", "key": "ref5", "unstructured": "Khan S, Saleem Y, Aziz S. Psychological response & perceived risk associated with coronavirus disease. Ann psychophysiol. 2020, 7:9-8. 10.29052/2412-3188.v7.i1.2020.9-18", "volume": "7", "year": "2020" }, { "DOI": "10.1211/PJ.2020.20208051", "article-title": "Investigational treatments for COVID-19", "author": "Trivedi A", "doi-asserted-by": "publisher", "journal-title": "Pharma J", "key": "ref6", "unstructured": "Trivedi A, Sharma S, Ashtey B. Investigational treatments for COVID-19. Pharma J. 2020, 304:10.1211/PJ.2020.20208051", "volume": "304", "year": "2020" }, { "article-title": "World Health Organization & United Nations Children's Fund (‎‎‎‎‎‎‎‎UNICEF)‎‎‎ Water, sanitation, hygiene and waste management for the COVID-19 virus: interim guidance", "key": "ref7", "unstructured": "Water, sanitation, hygiene and waste management for the COVID-19 virus. interim guidance. World Health Organization and the United Nations Children’s Fund (UNICEF), Geneva, Switzerland; 2020. https://apps.who.int/iris/bitstream/handle/10665/331846/WHO-2019-nCoV-IPC_WASH-2020.3-eng.pdf?sequence=1&isAllowed=y.", "year": "2020" }, { "key": "ref8", "unstructured": "National Institute of Health. Therapeutic management of adults with COVID-19. (2021). https://www.covid19treatmentguidelines.nih.gov/therapeutic-management/." }, { "key": "ref9", "unstructured": "Centers for Disease Control and Prevention. Coronavirus (COVID-19). Available at. https.//www.cdc.gov/coronavirus/2019-ncov/index.html.." }, { "DOI": "10.1001/jama.2019.2591", "article-title": "Preexposure prophylaxis for the prevention of hiv infection: evidence report and systematic review for the US Preventive Services Task Force", "author": "Chou R", "doi-asserted-by": "publisher", "journal-title": "JAMA", "key": "ref10", "unstructured": "Chou R, Evans C, Hoverman A, et al.. Preexposure prophylaxis for the prevention of hiv infection: evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2019, 321:2214-30. 10.1001/jama.2019.2591", "volume": "321", "year": "2019" }, { "DOI": "10.1056/NEJMoa2007764", "article-title": "Remdesivir for the treatment of Covid-19 - final report", "author": "Beigel JH", "doi-asserted-by": "publisher", "journal-title": "N Engl J Med", "key": "ref11", "unstructured": "Beigel JH, Tomashek KM, Dodd LE, et al.. Remdesivir for the treatment of Covid-19 - final report. N Engl J Med. 2020, 383:1813-26. 10.1056/NEJMoa2007764", "volume": "383", "year": "2020" }, { "DOI": "10.1093/cid/ciaa1041", "article-title": "Remdesivir for severe coronavirus disease 2019 (COVID-19) versus a cohort receiving standard of care", "author": "Olender SA", "doi-asserted-by": "publisher", "journal-title": "Clin Infect Dis", "key": "ref12", "unstructured": "Olender SA, Perez KK, Go AS, et al.. Remdesivir for severe coronavirus disease 2019 (COVID-19) versus a cohort receiving standard of care. Clin Infect Dis. 2021, 73:e4166-74. 10.1093/cid/ciaa1041", "volume": "73", "year": "2021" }, { "DOI": "10.1038/s41422-020-0282-0", "article-title": "Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro", "author": "Wang M", "doi-asserted-by": "publisher", "journal-title": "Cell Res", "key": "ref13", "unstructured": "Wang M, Cao R, Zhang L, et al.. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020, 30:269-71. 10.1038/s41422-020-0282-0", "volume": "30", "year": "2020" }, { "DOI": "10.1038/s41421-020-0156-0", "article-title": "Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro", "author": "Liu J", "doi-asserted-by": "publisher", "journal-title": "Cell Discov", "key": "ref14", "unstructured": "Liu J, Cao R, Xu M, et al.. Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro. Cell Discov. 2020, 6:16. 10.1038/s41421-020-0156-0", "volume": "6", "year": "2020" }, { "DOI": "10.1093/cid/ciaa237", "article-title": "In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)", "author": "Yao X", "doi-asserted-by": "publisher", "journal-title": "Clin Infect Dis", "key": "ref15", "unstructured": "Yao X, Ye F, Zhang M, et al.. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis. 2020, 71:732-9. 10.1093/cid/ciaa237", "volume": "71", "year": "2020" }, { "DOI": "10.1001/jama.2020.6019", "article-title": "Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review", "author": "Sanders JM", "doi-asserted-by": "publisher", "journal-title": "JAMA", "key": "ref16", "unstructured": "Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB. Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review. JAMA. 2020, 323:1824-36. 10.1001/jama.2020.6019", "volume": "323", "year": "2020" }, { "DOI": "10.1186/1743-422X-2-69", "article-title": "Chloroquine is a potent inhibitor of SARS coronavirus infection and spread", "author": "Vincent MJ", "doi-asserted-by": "publisher", "journal-title": "Virol J", "key": "ref17", "unstructured": "Vincent MJ, Bergeron E, Benjannet S, et al.. Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. Virol J. 2005, 2:69. 10.1186/1743-422X-2-69", "volume": "2", "year": "2005" }, { "DOI": "10.1056/NEJMoa2016638", "article-title": "A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19", "author": "Boulware DR", "doi-asserted-by": "publisher", "journal-title": "N Engl J Med", "key": "ref18", "unstructured": "Boulware DR, Pullen MF, Bangdiwala AS, et al.. A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19. N Engl J Med. 2020, 383:517-25. 10.1056/NEJMoa2016638", "volume": "383", "year": "2020" }, { "DOI": "10.1101/2021.05.17.21257012", "article-title": "Pre-exposure prophylaxis with various doses of hdroxychloroquine [sic] among high-risk COVID 19 healthcare personnel: CHEER randomized controlled trial [PREPRINT]", "author": "Syed F", "doi-asserted-by": "publisher", "journal-title": "medRxiv", "key": "ref19", "unstructured": "Syed F, Arif MA, Niazi R, et al.. Pre-exposure prophylaxis with various doses of hdroxychloroquine [sic] among high-risk COVID 19 healthcare personnel: CHEER randomized controlled trial [PREPRINT]. medRxiv. 2021, 10.1101/2021.05.17.21257012", "year": "2021" }, { "key": "ref20", "unstructured": "ClinicalTrials.gov. Efficacy of various doses of hydroxychloroquine in pre-exposure prophylaxis for COVID 19 (CHEER). (2020). https://clinicaltrials.gov/ct2/show/NCT04359537?term=NCT04359537&draw=2&rank=1." }, { "DOI": "10.3201/eid1002.030534", "article-title": "SARS transmission among hospital workers in Hong Kong", "author": "Lau JT", "doi-asserted-by": "publisher", "journal-title": "Emerg Infect Dis", "key": "ref21", "unstructured": "Lau JT, Fung KS, Wong TW, et al.. SARS transmission among hospital workers in Hong Kong. Emerg Infect Dis. 2004, 10:280-6. 10.3201/eid1002.030534", "volume": "10", "year": "2004" }, { "DOI": "10.1186/s13063-020-04621-7", "article-title": "Pre-exposure prophylaxis with hydroxychloroquine for high-risk healthcare workers during the COVID-19 pandemic: a structured summary of a study protocol for a multicentre, double-blind randomized controlled trial", "author": "Grau-Pujol B", "doi-asserted-by": "publisher", "journal-title": "Trials", "key": "ref22", "unstructured": "Grau-Pujol B, Camprubí D, Marti-Soler H, Fernández-Pardos M, Guinovart C, Muñoz J. Pre-exposure prophylaxis with hydroxychloroquine for high-risk healthcare workers during the COVID-19 pandemic: a structured summary of a study protocol for a multicentre, double-blind randomized controlled trial. Trials. 2020, 21:688. 10.1186/s13063-020-04621-7", "volume": "21", "year": "2020" }, { "DOI": "10.1001/jamainternmed.2020.6319", "article-title": "Efficacy and safety of hydroxychloroquine vs placebo for pre-exposure SARS-CoV-2 prophylaxis among health care workers: a randomized clinical trial", "author": "Abella BS", "doi-asserted-by": "publisher", "journal-title": "JAMA Intern Med", "key": "ref23", "unstructured": "Abella BS, Jolkovsky EL, Biney BT, et al.. Efficacy and safety of hydroxychloroquine vs placebo for pre-exposure SARS-CoV-2 prophylaxis among health care workers: a randomized clinical trial. JAMA Intern Med. 2021, 181:195-202. 10.1001/jamainternmed.2020.6319", "volume": "181", "year": "2021" }, { "DOI": "10.15585/mmwr.mm6915e6", "article-title": "Characteristics of health care personnel with COVID-19 - United States, February 12-April 9, 2020", "doi-asserted-by": "publisher", "journal-title": "MMWR Morb Mortal Wkly Rep", "key": "ref24", "unstructured": "Characteristics of health care personnel with COVID-19 - United States, February 12-April 9, 2020. MMWR Morb Mortal Wkly Rep. 2020, 69.477-81. 10.15585/mmwr.mm6915e6", "volume": "69", "year": "2020" }, { "DOI": "10.1128/AAC.00339-08", "article-title": "Pharmacokinetics of hydroxychloroquine and its clinical implications in chemoprophylaxis against malaria caused by Plasmodium vivax", "author": "Lim HS", "doi-asserted-by": "publisher", "journal-title": "Antimicrob Agents Chemother", "key": "ref25", "unstructured": "Lim HS, Im JS, Cho JY, et al.. Pharmacokinetics of hydroxychloroquine and its clinical implications in chemoprophylaxis against malaria caused by Plasmodium vivax. Antimicrob Agents Chemother. 2009, 53:1468-75. 10.1128/AAC.00339-08", "volume": "53", "year": "2009" }, { "DOI": "10.1186/s13063-021-05758-9", "article-title": "Pre-exposure prophylaxis with hydroxychloroquine for COVID-19: a double-blind, placebo-controlled randomized clinical trial", "author": "Grau-Pujol B", "doi-asserted-by": "publisher", "journal-title": "Trials", "key": "ref26", "unstructured": "Grau-Pujol B, Camprubí-Ferrer D, Marti-Soler H, et al.. Pre-exposure prophylaxis with hydroxychloroquine for COVID-19: a double-blind, placebo-controlled randomized clinical trial. Trials. 2021, 22:808. 10.1186/s13063-021-05758-9", "volume": "22", "year": "2021" } ], "reference-count": 26, "references-count": 26, "relation": {}, "score": 1, "short-container-title": [], "short-title": [], "source": "Crossref", "subject": [ "Aerospace Engineering" ], "subtitle": [], "title": [ "Pre-exposure Prophylaxis With Various Doses of Hydroxychloroquine Among Healthcare Personnel With High-Risk Exposure to COVID-19: A Randomized Controlled Trial" ], "type": "journal-article" }